"First, our overarching objective is to increase the number of Brazilian patients annually treated with AstraZeneca products from around 3.2 million today to over five million…
In Conversation
"As the premier research based company in the world, we are strongly committed to remain at the forefront of the Polish innovative landscape."
"We are not only interested in global or territorial rights to products that we can in-license or acquire, but want to secure manufacturing rights for those…
"I personally believe that the first and foremost mission of any general manager is to build and enhance enriching work relationships – both at the internal…
"Rare diseases affect – in total - a large population. However, individual rare diseases are very heterogeneous and people affected by these as well as their…
Looking at our productivity in 2017 alone, which includes three new therapy approvals, it is clear that the model we established makes good sense
"Serbia really has a huge potential especially in the innovation and technology sectors, but current developments in these areas are still modest."
"As for healthcare management, we have to ensure that people shaping new healthcare policies in the country are well educated from technical and scientific standpoints and…
"Apollo Telemedicine is working very closely with different state governments and providing telemedicine solutions to a large section of people who do not have access to…
"Our main competitive advantage on international markets relates to the proven quality of the pharmaceutical products developed and manufactured in Brazil."
"Canada has always been known for our great research, but an area where Canada is lagging behind significantly is the commercialization of products."
"We have the highest coverage of citizens of any country in Europe, which has been highlighted by studies by the OECD and the London School of…
